(Q43723284)

English

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

author name string

Michon JM

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Hartmann O

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Bouffet E

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Meresse V

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Coze C

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Rubie H

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Bordigoni P

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Cattiaux E

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Ward N

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Bernard JL

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Lemerle J

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Zucker JM

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Philip T

13

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1063-1069

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Where next with therapy in advanced neuroblastoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose rapid schedule chemotherapy for disseminated neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900061-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(98)00061-6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43723284&oldid=2102844288"